BMX — BioMaxima SA Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro CapContrarian
- PLN125.31m
- PLN113.63m
- PLN81.09m
- 95
- 77
- 22
- 74
Annual income statement for BioMaxima SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | PAS | PAS | PAS | PAS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 31.6 | 30.8 | 30.5 | 61.6 | 81.1 |
Cost of Revenue | |||||
Gross Profit | 13.1 | 13.3 | 13 | 23.9 | 32.1 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 30.6 | 31.1 | 29.9 | 52.2 | 68.1 |
Operating Profit | 1.01 | -0.302 | 0.629 | 9.4 | 13 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.926 | -0.532 | 0.182 | 8.75 | 12.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.838 | -0.462 | 0.014 | 7.33 | 10.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 0.806 | -0.482 | -0.014 | 7.36 | 10.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.806 | -0.482 | -0.014 | 7.36 | 10.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.235 | -0.068 | 0.026 | 1.8 | 2.41 |
Dividends per Share |